Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma

To analyze whether neoadjuvant chemotherapy (NAC) changes the expression rates of invasive ductal carcinoma (IDC) markers: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki67, and P53. This was a retrospective study of 112 IDC patients who underw...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Main Authors: Peng, Jian-Heng, Zhang, Xiang, Song, Jun-Long, Ran, Liang, Luo, Rong, Li, Hong-Yuan, Wang, Yong-Hong
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer Health 2019
Assuntos:
5750
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336639/
https://ncbi.nlm.nih.gov/pubmed/30633152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013554
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares